Tenet Healthcare (NYSE:THC) Hits New 12-Month High – Here’s What Happened

Posted by Geri Gentry on Aug 24th, 2026

Tenet Healthcare Corporation (NYSE:THC – Get Free Report)’s share price reached a new 52-week high on Monday . The company traded as high as $284.60 and last traded at $284.60, with a volume of 476 shares traded. The stock had previously closed at $280.77.

Analyst Upgrades and Downgrades

THC has been the topic of several recent analyst reports. Raymond James Financial reaffirmed an “outperform” rating and issued a $285.00 price target on shares of Tenet Healthcare in a research note on Friday, August 14th. Wells Fargo & Company lifted their price target on Tenet Healthcare from $231.00 to $281.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Royal Bank Of Canada lifted their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. Guggenheim upped their target price on Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a research report on Tuesday, July 28th. Finally, Mizuho set a $290.00 price target on shares of Tenet Healthcare in a report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $273.00.

Get Our Latest Stock Analysis on Tenet Healthcare

Tenet Healthcare Trading Up 1.4%

The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The company has a 50 day moving average of $220.53 and a 200 day moving average of $206.93. The stock has a market capitalization of $22.92 billion, a price-to-earnings ratio of 10.98, a P/E/G ratio of 1.07 and a beta of 1.23.

Tenet Healthcare (NYSE:THC – Get Free Report) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, research analysts predict that Tenet Healthcare Corporation will post 20.97 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Lisa Y. Foo sold 10,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $258.03, for a total value of $2,580,300.00. Following the completion of the sale, the executive vice president owned 32,053 shares in the company, valued at approximately $8,270,635.59. This trade represents a 23.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Roy Blunt sold 600 shares of the stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $262.68, for a total value of $157,608.00. Following the transaction, the director directly owned 4,589 shares in the company, valued at approximately $1,205,438.52. The trade was a 11.56% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 41,375 shares of company stock valued at $9,793,347. Insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

A number of hedge funds have recently added to or reduced their stakes in THC. California State Teachers Retirement System lifted its position in Tenet Healthcare by 18,362.2% in the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock valued at $3,533,142,000 after acquiring an additional 18,783,432 shares during the last quarter. Norges Bank purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth approximately $248,494,000. Wellington Management Group LLP lifted its holdings in shares of Tenet Healthcare by 1,114.2% during the fourth quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares during the period. Manning & Napier Advisors LLC acquired a new position in Tenet Healthcare in the 2nd quarter valued at $168,761,000. Finally, Boston Partners raised its holdings in Tenet Healthcare by 38.8% during the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.